Jennifer Zachry
Co-Founder, Director, Business Development Orion Therapeutics
Dr. Jennifer Zachry has been a pivotal part of Orion’s growth over the past three years as a co-founder and the Director of Business Development. She holds a PhD in Pharmacology from Vanderbilt University and an MBA from the University of Tennessee Knoxville with expertise in Neuroscience, where she published in top-tier academic journals, including Nature Neuroscience and Neuron, and won multiple awards and recognition for her work. Jennifer’s strategic vision and business acumen have driven Orion’s market strategy, positioning Orion as a genetic medicine company enabled by a novel delivery platform. She has led Orion to win several awards, including the Eli Lilly Genetic Grand Medicine Challenge, the Chiesi Golden Ticket Challenge, several grants, and others.
Seminars
- Enhanced Stability & Scalable Manufacturing – Lipopeptides form highly stable particles that protect RNA during processing and storage, enabling reproducible largescale production and simplified cold-chain logistics
- Improved Safety Profile – Ionizable-lipid-free design reduces inflammatory and toxic responses, supporting repeated dosing and broad therapeutic use
- Precise Extra-Hepatic Delivery – Cell-penetrating and targeting functions allow efficient uptake beyond the liver, expanding RNA therapy to cardiovascular, pulmonary, and other hard-to-reach tissues. Case study of gene therapy for use in vascular disease application enabled by GENESYS™ targeted delivery platform
NEW COMPANY
